Terms Of Use - JanOne

FAQ
Investors

Why We Exist
Pipeline
The Pain Truth
About PAD
Our Company
News
FAQ
Investors
FOLLOW THE PROGRESS

JanOne is a pharmaceutical company focused on finding treatments for conditions that cause severe pain and bringing to market drugs with non-addictive pain-relieving properties. As a result, we hope to reduce the need for prescribing dangerous opioid drugs. Our first drug candidate is a treatment for Peripheral Arterial Disease (PAD), a condition that can cause severe pain and affects over 8.5 million people in the US alone.

The company trades under the symbol JAN on the NASDAQ and continues to independently operate its subsidiary business – Appliance Recycling Centers of America, Inc (ARCA).

Latest News

JanOne on Twitter

Why We Exist
Pipeline
The Pain Truth
About PAD
Our Company
News
FAQs
Investors
Contact

Stay Up To Date

×

Follow JanOne’s progress on fighting the opioid crisis and developing solutions that kill pain, not people.

Share Your Story

Have you, a family member or friend suffered from addiction as a result of prescription opioids? We would love to hear your story.

Seraphinite Accelerator

Optimized by Seraphinite Accelerator
Turns on site high speed to be attractive for people and search engines.